Landmark studies have demonstrated that fecal microbiota transplantation from cancer patients who had responded to anti-PD-1 therapy improved the effects of PD-1 blockade in germ-free or antibiotic-treated mice (97–99). The gene discussed is PDCD1; the disease is cancer.